|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Encore Medical Corporation (Nasdaq: ENMC), a diversified orthopedic device manufacturer. |
|---|---|
| Transferring Party | Compex Technologies, Inc., a leader in designing and manufacturing transcutaneous electrical nerve stimulation and electrical muscle stimulation (EMS) products used for pain management, rehabilitation and other medical settings. |
| Sector | Medical Devices |
| Date | February 27, 2006 |
| Analysis Creates a stronger orthopedic products company that will combine leading electrical stimulation pain management and rehabilitation companies -- Encore's Orthopedic Rehabilitation Division, which includes Empi and Chattanooga Group, and Compex, formerly Rehabilicare. Deal valued at approximately $109m. Compex's sales for fiscal 05 were $96.1m (1.13x) and its operating profit was $4.6m (22.4x). | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |